SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Cardiovascular Pharmacology and Therapeutics
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Klugherz, B. D.
Right arrow Articles by Wilensky, R. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Klugherz, B. D.
Right arrow Articles by Wilensky, R. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Sustained Intramural Retention and Regional Redistribution Following Local Vascular Delivery of Polylactic-Coglycolic Acid and Liposomal Nanoparticulate Formulations Containing Probucol

Bruce D. Klugherz

University of Pennsylvania Medical Center

Nicolas Meneveau

University of Pennsylvania Medical Center

Weiliam Chen

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

Fran Wade-Whittaker

University of Pennsylvania Medical Center

George Papandreou

Cordis Corporation, Warren, New Jersey

Robert Levy

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

Robert L. Wilensky

University of Pennsylvania Medical Center

Background: Probucol reduces restenosis after angioplasty, provided oral administration is begun 1 month before the procedure. Local vascular delivery of a nanoparticulate formula tion of probucol may obviate the need for drug loading by acutely raising arterial intramu ral concentration while providing sustained intramural retention. To test this hypothesis, we compared the retention and redistribution of 35S-probucol encapsulated in either liposomal or polylactic-coglycolic acid (PLGA) nanoparticles after local vascular delivery.

Methods: Nanoparticles were delivered using a Crescendo microporous infusion catheter (Cordis, Warren, NJ) after balloon angioplasty of rabbit iliac arteries (n = 12-18 arteries per formulation per time point). Animals were euthanized on day 0, 3, or 7 after delivery. Iliac arteries, perivascular fat, and downstream tissues were harvested and the radioactivity disintegrations per minute was measured. Autoradiographic and confocal microscopic anal yses of tissue sections were performed to evaluate intramural distribution of probucol.

Results: Immediately after delivery, radioactivity in the iliac arteries (log[dpm/mg], mean ± SEM) was greater with PLGA (2.72 ± 0.08) than with liposomal encapsulation (2.10 ± 0.08, P = 0.001). Intramural retention of probucol was 23% at 7 days using liposomes and 10% using PLGA, corresponding to a probucol concentration of 0.1 ng/mg tissue for both formulations. By the third day after delivery, radioactivity in peri-iliac fat, femoral arteries, and hindlimb muscle increased by 88%, 29%, and 154%, respectively. Thereafter, radioac tivity decreased to 56%, 43%, and 134% of initial dpm respectively, by day 7.

Conclusions: Although delivery efficiency was superior with PLGA encapsulation, intra mural probucol concentrations were similar on day 7 using both formulations. Radial and axial redistribution of probucol was observed, indicating that this technique can be exploited to increase adjacent tissue delivery.

Key Words: drug delivery systems • antioxidant • balloon angioplasty.

Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 4, No. 3, 167-174 (1999)
DOI: 10.1177/107424849900400306


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement